The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer

Authors:

Abstract
No abstract available
Funding Information
  • EU project Pro-KinaseResearch (LSHB-CT-2004-503467)

This publication has 44 references indexed in Scilit: